These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 32478627
21. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review. Henegar CE, Eudy AM, Kharat V, Hill DD, Bennett D, Haight B. Lupus; 2016 May; 25(6):617-26. PubMed ID: 26743322 [Abstract] [Full Text] [Related]
22. Update οn the diagnosis and management of systemic lupus erythematosus. Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219 [Abstract] [Full Text] [Related]
23. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Vázquez-Otero I, Medina-Cintrón N, Arroyo-Ávila M, González-Sepúlveda L, Vilá LM. Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863 [Abstract] [Full Text] [Related]
24. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption. Takamasu E, Yokogawa N, Shimada K, Sugii S. Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325 [Abstract] [Full Text] [Related]
25. Systemic lupus erythematosus: an update. Golder V, Hoi A. Med J Aust; 2017 Mar 20; 206(5):215-220. PubMed ID: 28301792 [Abstract] [Full Text] [Related]
27. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus. Zamora LD, Collante MTM, Navarra SV. Int J Rheum Dis; 2020 Feb 20; 23(2):197-202. PubMed ID: 31692250 [Abstract] [Full Text] [Related]
28. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management. Mehta P, Gasparyan AY, Zimba O, Kitas GD. Clin Rheumatol; 2022 Sep 20; 41(9):2893-2910. PubMed ID: 35639259 [Abstract] [Full Text] [Related]
29. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senécal JL, Cividino A, Danoff D, Osterland CK, Yeadon C, Smith CD. Lupus; 1998 Sep 20; 7(2):80-5. PubMed ID: 9541091 [Abstract] [Full Text] [Related]
30. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report. Danve A, Perry L, Deodhar A. Semin Arthritis Rheum; 2014 Oct 20; 44(2):195-7. PubMed ID: 25005336 [Abstract] [Full Text] [Related]
31. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus. Paredes-Ruiz D, Martin-Iglesias D, Ruiz-Irastorza G. Expert Rev Clin Immunol; 2024 Apr 20; 20(4):359-373. PubMed ID: 38112074 [Abstract] [Full Text] [Related]
32. Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus. Chang JC, Costenbader KH. Semin Arthritis Rheum; 2022 Oct 20; 56():152042. PubMed ID: 35738041 [Abstract] [Full Text] [Related]
33. Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations. Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K. Clin Rheumatol; 2019 Oct 20; 38(10):2785-2791. PubMed ID: 31175481 [Abstract] [Full Text] [Related]
34. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Teh CL, Wan SA, Ling GR. Clin Rheumatol; 2018 Aug 20; 37(8):2081-2086. PubMed ID: 29667100 [Abstract] [Full Text] [Related]
35. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review. Constantin A, Năstase D, Tulbă D, Bălănescu P, Băicuș C. Lupus; 2020 Oct 20; 29(12):1509-1519. PubMed ID: 32757735 [Abstract] [Full Text] [Related]
36. Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies. Conigliaro P, Triggianese P, Draghessi G, Canofari C, Aloe G, Chimenti MS, Valeri C, Nucci C, Perricone R, Cesareo M. Int Arch Allergy Immunol; 2018 Oct 20; 177(1):45-56. PubMed ID: 29902805 [Abstract] [Full Text] [Related]
37. Risk Factors and Incidence of Serious Infections in Patients With Systemic Lupus Erythematosus Undergoing Rituximab Therapy. Sun YS, Huang DF, Chen WS, Liao HT, Chen MH, Tsai MT, Yang CY, Lai CC, Tsai CY. J Rheumatol; 2024 Feb 01; 51(2):160-167. PubMed ID: 37839817 [Abstract] [Full Text] [Related]
38. Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis. Shamliyan TA, Dospinescu P. Clin Ther; 2017 Jul 01; 39(7):1479-1506.e45. PubMed ID: 28673504 [Abstract] [Full Text] [Related]
39. Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus. Kan H, Nagar S, Patel J, Wallace DJ, Molta C, Chang DJ. Clin Ther; 2016 Mar 01; 38(3):610-24. PubMed ID: 26907503 [Abstract] [Full Text] [Related]
40. Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-Response. Balevic SJ, Niu J, Chen J, Green D, McMahon A, Hornik CP, Schanberg LE, Glaser R, Gonzalez D, Burckart GJ. J Clin Pharmacol; 2023 Jan 01; 63(1):105-118. PubMed ID: 35968821 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]